Abeona Therapeutics Joins Rare Disease Company Coalition

Abeona Therapeutics Inc. (Nasdaq: ABEO) has recently become a member of the Rare Disease Company Coalition (RDCC), a coalition consisting of life science companies that are committed to developing therapies for rare diseases. Vish Seshadri, the CEO of Abeona, has also been appointed to the RDCC's Board of Directors. Abeona is thrilled to join forces with the RDCC and shares their dedication to a..

  • format_list_bulleted Pharmacology/BS
  • · 2023. 7. 19.
  • textsms

Abeona Therapeutics Announces Closing of $25 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Abeona Therapeutics Inc. (Nasdaq: ABEO) has successfully completed a registered direct offering, raising an impressive $25 million in gross proceeds. What's even more remarkable is that this offering was carried out without any discounts or warrant coverage, highlighting the unwavering confidence of existing institutional investors in Abeona. The purpose behind this fundraising success is to pre..

  • format_list_bulleted Pharmacology/BS
  • · 2023. 7. 10.
  • textsms